2nd International Congress on Lung Cancer: Crete, Greece, November 9 - 13, 1996
Gespeichert in:
| Körperschaft: | |
|---|---|
| Format: | Tagungsbericht Buch |
| Sprache: | English |
| Veröffentlicht: |
Bologna
Monduzzi
1996
|
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | 701 S. Ill., graph. Darst. |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV011466683 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 970801s1996 ad|| |||| 10||| engod | ||
| 035 | |a (OCoLC)36598121 | ||
| 035 | |a (DE-599)BVBBV011466683 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 | ||
| 111 | 2 | |a International Congress on Lung Cancer |n 2 |d 1996 |j Verfasser |0 (DE-588)1236686-9 |4 aut | |
| 245 | 1 | 0 | |a 2nd International Congress on Lung Cancer |b Crete, Greece, November 9 - 13, 1996 |c ed. George Antypas |
| 246 | 1 | 3 | |a Second International Congress on Lung Cancer |
| 246 | 1 | 3 | |a Second International Congress on Lung Cancer |
| 264 | 1 | |a Bologna |b Monduzzi |c 1996 | |
| 300 | |a 701 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 650 | 4 | |a Lung Neoplasms |v Congresses | |
| 650 | 0 | 7 | |a Lungenkrebs |0 (DE-588)4036668-6 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1996 |z Kreta |2 gnd-content | |
| 689 | 0 | 0 | |a Lungenkrebs |0 (DE-588)4036668-6 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Antypas, George |e Sonstige |4 oth | |
| 856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007714091&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-007714091 | ||
Datensatz im Suchindex
| _version_ | 1804125985659944960 |
|---|---|
| adam_text | INDEX
HISTORY
G.P. STATHOPOULOS
Natural history of lung cancer 3
DIAGNOSIS
C.F. MOUNTAIN
Lung cancer staging: 1997 revisions 11
S. KRISTENSEN and S.M. NIELSEN
Mediastinal staging of non small cell lung cancer. Regional accuracy of comput¬
ed tomography 15
D. BUTfflAU, E. ANTOINE, D. NIZRI, D. KHAYAT,
J.C. PIETTE and P. BALDEYROU
Virtual tracheo bronchial endoscopy: educational and diagnostic value in lung
cancer 19
G.E. CHALKIADAKIS
Lung cancer surgery for N/N^ mediastinal disease 27
M.C. DUMON
Laser bronchoscopy 33
K. ILIADIS
Mediastinoscopy in the staging of lung cancer 39
Ap. APOSTOLOU, 01. BANAVA IOANNOU, Ar. MANDRALI,
P. SEVASTIADOU, F. ZOGLOPITIS
and Asp. BIZIAGOU HASIOTOU
Cytologic approach of lung cancer with bronchoscopic methods. A review about
a 5 year period 43
N.G. CAVALLESCO, L. LUPI, R. MELONCELLI, N. CALIA,
F. RAVENNA, M. LODI and G.T. AZZENA
Videothoracoscopic treatment of recurrent pleural effusion with talc poudrage . 49
S. CICENAS, K. VALUCKAS and M. AIZENAS
Endobronchial combined treatment of non small cell lung cancer 55
G. DELLA ROCCA, L. POMPEI, M. ANTONINI, F. PUGLIESE,
C. COCOA, M. MARim, F. VENUTA, T. DE GIACOMO,
E.A. RENDINA and C. RICCI
Lung cancer and obstruction of upper airway: anesthesia in spontaneously assist¬
ed ventilation for Nd: Yag laser resection 61
D. ORPHANIDOU
Prognostic factors in lung cancer. Biological markers 67
N.E. KUSHLINSKY, N.V. LYUBIMOVA and A.O. LEMESHKO
Serum CYFRA 21 1 and neuron specific enolase as markers of lung cancer . . 75
H.L. ROSS, T. LJJLOGLOU, A. SWIFT, W. PRIME, J. GOSNEY,
R.J. DONNELLY and J.K. FIELD
Early molecular biomarkers in lung cancer 79
T.H. WIETHEGE, K M. MULLER, K. WEGENER, A. SPIETHOFF,
M. CASTRO and H. WESCH
Histomorphological types of lung cancer in German uranium miners 83
H. TSIMARA PAPASTAMATIOU
Paraneoplastic syndromes associated with lung cancer 89
T. TAKAHASHI, M. MORI and R. CHIBA
Adenocarcinoma and related lesions of the lung: cellular morphometry correlat¬
ed with immunocytochemistry 95
D. D ADDA, M.M. MARUZZI, C. SARTINI, F. FERRARA,
L. DALL ASTA and F. FRASCHINI
Alveolar macrophages activity in patients with lung cancer 103
A. GIATROMANOLAKI, M.I. KOUKOURAKIS, K. O BYRNE,
R. WHITEHOUSE, K.C. GATTER and A.L. HARRIS
Plasma cell, macrophage infiltration and tumour neo angio gene sis in non small
cell lung cancer 107
K. JUNKER, V. KLINKE, U. BOSSE, M. THOMAS
and K.M. MULLER
Tumor regression in non small cell lung cancer 113
Lj. VUCKOVIC DEKIC, N. STANOJEVIC BAKIC, L. RAJNER,
M. DEKIC and M.C. PESIC
The in vivo and in vitro effects of Thymex L on lymphocytes of irradiated lung
cancer patients 119
T. DAHABREH
Solitary pulmonary nodule (SPN) 123
T.J. DOSIOS
The need for a consensus concerning a more efficient and less expensive post¬
operative follow up of patients with bronchogenic carcinoma 127
N. ODARTCHENKO
The dissemination of knowledge on lung cancer via international publications . 135
A. TAVERNARAKI, Th. ALEXIU, E. ANDRIOTIS, K. DELIVELIOTIS,
V. KORONIS, A. SIGALAS, K. RAPTIS and T. DAHABRE
CT guided fine needle aspiration biopsy in the diagnosis of lung cancer 139
T.P. BELIKOVA, I.I. STENINA
and N.O. YASHUNSKAYA
Early diagnosis of peripheral lung cancer on the base of image processing and •
syndrome features analysis 145
R. BILANCIA, G. CAPUTO, G. CANTACESSI, R. MACERI,
A. GRECO and A. POSCA
Cell mediated immunity in patients with pulmonary carcinoma 151
V. CANGEMI, P. VOLPINO, N. D ANDREA, F. SCOPINARO,
. O. SCHILLACI and G. PIAT
Reliability of Technetium 99M tetrofosmin scanning for imaging lung cancer de¬
tection 155
P. FAZZI, S. SOLFANELLI, A. IANNI and C. GIUNTINI
Scintigraphic images subtraction (SIS) technique in staging lung cancer 159
PL. FILOSSO, M. BELLO, G. BISI, G. CANAVESE, A. MUNI,
C. CASADIO and A. OLIARO
Lung cancer and 111 In octreotide scintigraphy 163
C. GIANNAKENAS, H.P. KALOFONOS, D. APOSTOLOPOULOS,
A. CHONDROMARAS, S.D. YARMENITIS,
T. PETSAS and P.J. VASSELAKOS
1 Scintigraphic detection of SCLC with a radiolabeled somatostatin analogue [in
]ll DTPA Phe l] octreotide 169
J. GRYMNSKI, L. PAWLICKA, E. ROWINSKA,
Z. PIASECKI and A. DRYGALSKA
Ultrasound and radiological evaluation of the results of chemotherapy of small
cell lung cancer (SCLC) in pahents with abdominal metastases 173
D. JOVANOVIC BORIKIC, J. MARINKOVIC and D. STANISAVLJEVIC
¦ Dynamics of alterations of monitored features during follow up 200 cases of lung
cancer and behaviour of NSCLC and SCLC patients as compared to these altera¬
tions 179
T. MIYAMOTO, J. TAKAFUJI, I. SEKINE, H. OHMATSU, R. KAKINUMA,
T. KODAMA, Y. NISHIWAKI, K. NAGAI and N. MORIYAMA
CT fluoroscopically guided transthoracic needle biopsy 183
G. POTENTE, F. PALMEGGIANI, V. IACARI, F. MACORI, M. CAMI,
A. MlSm and G. ANAVERI
The role of HRCT in differentiating benign from malignant solitary pulmonary I
nodules 189
V. PASTORE, L. MANSI, P.F. RAMBALDI, E. DI LIETO, j
M. DELLA VITTORIA, F. FALLANCA and G. CASCINI |
Tc 99m tetrofosmin uptake in lung carcinomas 193 j
Ch. PSACHOULIA, M. KARDARI, P. LABROPOULOU, P. XIROU,
A. GEROKOSTA, E. KALADELFOU and CD. SCOPA
Expression of PCNA in fine needle aspiration (FNA) biopsies of lung cancer . . 197 i
I. SCHMITZ, K. KNECHT, E. TOLNAY and K.M. MULLER |
Characterization of the paravascular zone in lung tumors of different degrees of
differentiation 203
W. SCHUTTE, T. BLANKENBURG, ST. SCHADLICH
and I. REPPE ;
Activated coagulation and fibrinolysis in patients with lung cancer the influen j
ce of chemotherapy 209 j
K. SEMIANOWICZ, J. GMINSKI, A. TELEGA, M. GOSS, |
M. MACHALSKI, M. STAJSZCZYK and W. WOJAKOWSKI
Serum lipid profile in patients with squamous cell and small cell lung cancer. . 213
E. SKOPINSKA ROZEWSKA, E. SOMMER, U. DEMKOW, B. BALAN,
E. BARCZ, E. ROGALA, E. SIKORSKA,
J. SLODKOWSKA and S. MLEKODAJ
Modulation of angiogenesis by sera of patients with lung cancer 219
D. SURCEL, O. ROTARU, Z. ANCA, S. RAMBOIU,
R. OLINESCU and L. CHEREJI
The effect of isorel on lung cellular response in experimental exposure to asbes¬
tos 223
J. TOCILJ, B. BOTA, K. MISE, I. PINTARIC, S. JANKOVIC
and A. BRADARIC
Radiological findings and lung function parameters in pulmonary parenchymal
and pleural asbestosis 229
F. GUDDO, A.M. VIGNOLA, C. REINA, C. PATRIARCA, J. HILKENS,
G. PRUNERI, R. BUFFA and G. BONSIGNORE
Episialin (EMA, MUC1) expression in lung cancer 233
F. VLASTOS, P. GEORGAKOPOULOS, M. DIMADI, A. AGGELIDOU,
D. KAZOS, V. SOTIROPOULOU and E. PAPADAKIS
Ultrasound guided needle aspiration biopsy for peripheral pulmonary lesions . Til
P. VOLPINO, V. CANGEMI, N. D ANDREA, F. SCOPINARO,
B. CANGEMI and G. PIAT
Accuracy of regional perfusion and ventilation scanning in predicting pulmonary
function after surgery for lung cancer 243
CLINICAL PROBLEMS
D. ANTONIOU
Clinical presentation and symptoms of lung cancer 249
V. BELTRAMI and A. BUONSANTO
A correlation hypothesis between personality profile and clinical history of lung
cancer patients 255
I. COLL, M. RODRIGUEZ CARBALLEIRA, R. BASTUS, R. RAM,
J.L. HEREDIA, G. GONZALEZ and L. CIRERA
Small cell lung cancer (SCLC): analysis of 100 consecutive cases 259
M.B. BYCHKOV, V.A. GORBUNOVA and N.F. OREL
Analysis of long term survival patients with small cell lung cancer (SCLC) . . . 263
T. GEORGIEV, Tz. BOSHNAKOVA and T. TODOROV
Neuroendocrine tumours of the lung 267
Z. GLEDOVIC, M. JAREBINSKI, T. PEKMEZOVIC, I. JEVREMOVIC,
O. BOJOVIC, D. ZIVKOVIC and V. CEMERIKIC
Lung cancer mortality in Belgrade (Yugoslavia) 275
O. KAWASHIMA, T. MIRAI, M. KAMIYOSHIHARA
and Y. MORISHITA
Primary pulmonary lymphoma: what is a suitable treatment for this unusual dis¬
ease? 279
V. MICHAILOVA, R. DREBOV, I. CHRISTOVA
and TZ. BOSHNAKOVA
Mediastinal teratomas in children 285
S. MORAITIS, G. KONTOGIANNIS, A. CHATZIMCHALIS, A. LOUTSIDIS,
I. BELLENIS and N. EXARCHOS
Carcinoid tumors of the lung 289
Lj. NAGORNI OBRADOVIC and V. CEMERIKIC
i Superior vena cava syndrome as the first dominant symptom in lung cancer. . . 293
I. PEREIRA, J. COSTEIRA, A. COSTA, M. CRISTOVAO,
M. MELO and C. MACHADO
A clinical analysis of lung cancer in Portuguese women 297
G. RADOSAVLJEVIC ASIC, Z. USKOKOVIC, D. SUBOTIC
and N. ATANASIJADES
Pleural mesothelioma therapeutical problem 301
M.L. OLIVEIRA, L.C. MATOS, F. NOGUEIRA
and M.C. DE ABREU
Multiple primary cancers. A 6 years review 307
J. VTOENOVIC IVANOV, O. DURIC and V. VUCINIC
Lung cancer and viral pneumonias 311
E. AULBERT
Palliative care in poor prognosis SCLC patients 315
G.A. RIGATOS
Quality of life in incurable / no treatment cases of lung cancer 321
G.A. RIGATOS
Quality of life: definitions; QOL in clinical trials; ethical problems 325
H. NEEF, R. FIEDLER, H. HENNIG, W. ROSENDAHL
and C. LAUTENSCHLAGER
Functional late results and quality of life after pneumonectomy. Impact of oper¬
ation and adjuvant therapy 329
V. PASTORE, M. SANTINI, G. VICIDOMINI, S. DE LUCA j
and S. TRIGGIANI
Quality of life after resection for lung cancer: predictability of postoperative
FEVl 335
D. RADOSAVLJEVIC, S. JELIC, D. GAVRILOVIC, S. RADULOVIC, |
V. KOVCIN and V. SOBIC !
ECOG scale and Rotterdam symptom checklist in assessment of quality of lije j
(QL) in patients with advanced non small cell lung cancer (SCLC) treated with
chemotherapy N. THATCHER
Prognostic factors in small cell lung cancer ^ /
M. TOUMBIS
Prognostic factors and standing in lung cancer M ;
J.A. LANGENDIJK, FB.J.M. THUNNISSEN, R.J.S. LAMERS,
J.M.A. DE JONG, G.P.M. TEN VELDE, ;
J.W. ARENDS and E.F.M. WOUTERS |
The predictive and prognostic value of the expression of p53 and be 1 2 in non j
small cell lung carcinoma treated by radiotherapy 35 / j
I. SEKINE, K. NAGAI, Y. NISHIWAKI, T. KODAMA, N. ABE, j
S. TSUGANE, T. OGURA and H. ESUM
Does smoking or family history influence the prognosis of patients with non small ^
cell lung cancer?
T. SHIMOTAKAHARA, T. AIKOU, H. NISHIJIMA, H. MATSUMOTO,
M. YANAGI, H. OGAWA and H. TOYOYAMA
The significance of tumor cells in intraoperative pleural lavage an indicator for
the poor prognosis of lung cancer and therapy 369
T. TAKIZAWA, M. TERASfflMA, T. KOIKE and T. AOKI
Survival determinants in patients with stage Ilia, N2 non small cell lung cancer
underwent complete resection 375
TREATMENT
D. ANTONADOU
Brachytherapy in lung cancer 383
E.E. MARANGOUDAKIS
Quality of life in radiation treatment for bronchogenic carcinoma 389
L. PETRUZELKA P. ZATLOUKAL and M. SEMANOVA
Impact of palliative radiotherapy in symptom management in lung cancer pa¬
tients 393
R.P. ABRATT, D.G.M. SALTON and J.R. MALAN
Combined chemotherapy and radiation for limited disease small cell lung cancer.
A prospective randomised study 399
J.S.P. JONES, A.R. GIBBS, J.C. McDONALD and F.D. POOLEY
Mesothelioma following exposure to crocidolite (blue asbestos). A fifty year follow
up study 407
A. JACKEVICIUS, S. CICENAS, E. ALEKNAVICIUS
and V. JAKELEVICIENE
Multimodality treatment of lung cancer 413
S. KOBAYASHI, S. OKADA, H. YOSHIDA and S. FUJIMURA
Combined modality therapy in stage III small cell lung cancer on the basis of the
sensitivity test in vitro 419
K. MSE, B. BOTA, J. TOCELJ, S. JANKOVIC,
A. PETRICEVIC and A. BRADARIC
Mesothelioma pleurae. Revaluation of the therapy 423
I. SMOLANKA, V. GANUL, M. DORFMAN and Yu. MEDINETS
Ways of improved efficacy in the combined treatment of lung cancer 427
M. THOMAS, C. RUBE, M. SEMIK, F. KLINKE,
M. VON EIFF and J. VAN DE LOO
Neoadjuvant combined treatment for stage III non small cell lung cancer (NSCLC):
results of a prospective phase II trial 43 1
K. ZAROGOULIDIS, A. PAPAGIANNIS, E. FAHANTIDOU,
P. HATZIAPOSTOLOU and T.C. CONSTANTINIDIS
The role of erythropoietin in the management of chemotherapy related anaemia
in patients with non small cell lung cancer 435
E.M. PAPADAKIS, G. BLAZOYANNAKIS, A. AGGELIDOU, A. VOSSOS,
O. GRIVAS, E. SINEFAKI, H. ANGELETOPOULOU, I. LAMPADITIS,
M. DIMADI, F. VLASTOS, M. VESSLEMES, M. MAVROMANOLAKIS,
J. VLAHONIKOLIS and S. TZANNES
A trial of combination chemotherapy of M.I. C. (Mitomycin C plus lfosfamide plus
Cisplatin) for stage I lib and IV patients suffering from non small cell lung cancer. 441
N.A. PAVLIDIS
Phase II studies with investigational drugs in lung cancer. The EORTC, Early
Clinical Trials Group (1990 1996) . 445
E. RAZIS
Lung cancer. Quality of life in chemotherapy 449
G.F. SAMELIS
Topoisomerase I inhibitors in the treatment of lung cancer 455
N. THATCHER
Dose intensifying treatment of small cell lung cancer (good prognosis) with pro¬
genitor bone marrow cell rescue 461
M. VESLEMES
Molecular mechanisms of drug resistance in lung cancer 465
K. ZAROGOULIDIS, K. FILIPPOU, C. ANTONIOU, A. PAPAGIANNIS,
P. HATZIAPOSTOLOU, P. TSIAGGA, j
M. CHRISTOFORIDIS and J. KANELLOS
The impact of adjuvant chemotherapy on the survival of postoperative stage MA
non small cell lung cancer patients 471
R. BILANCIA, D. MARGIOTTA, L. SCARAFILE, E. SPAMPANI,
G. SEBASTIO and P. ROSELLI
MPA protective action on chemotherapy induced leukopenia in patients with pul¬
monary carcinoma (PC) 477
M. BUDINGER, H. KLEIN and T. WELTE
Treatment of non small cell lung cancer with Paclitaxel/Carboplatin 481
M. DONGHI, P. ANTONELLI
and R. GIURA
Salvage chemotherapy with PEB for previously treated small cell lung cancer. . 487
PL. FILOSSO, S. BRETTI, M. BELLO, G. BISI, C. CASADIO, |
A. OLIARO and C. BUMMA i
Therapy with octreotide in neuroendocrine carcinomas of the lung 491
G. COLUCCI, V. GEBBIA, D. GALETTA, F. RICCARDI, S. SCODITTT,
P. TOMA, S. CARIELLO, G. PEZZELLA, E. DURINI,
R. LORENZO and G. PANDOLFO ;
A prospective randomized study of a sequence of cisplatin plus vinorelbine and
ifosfamide plus epirubicm versus the reverse sequence in stage III IV non small
cell lung cancer (NSCLC) 497
P. GINOPOULOS
Phase 11 study of taxol and carboplatin in advanced non small cell lung cancer 503
M. GUARALDI, A. MARTONI, A. PANETTA,
M. MINEO and F. PANNUTI
Second line chemotherapy with vinorelbine (VNR) in a selected group of patients
with non small cell lung cancer (NSCLC) in progression after first line cisplati ¦
num (CP) based regimen ^
U. HAUS, M. WOLF, K. HANS, P. DRINGS, H. GOSSE, D. UKENA,
E. HRUSKA, M. SCHROEDER, R. LOHMULLER, A. FOLLER,
K. EBERHARDT, M. DANNHAUSER, M. PRITSCH,
L. FARBER and K. HAVEMANN
Granulocyte macrophage colony stimulating factor (rhGM CSF) in 302 patients
with small cell lung cancer
O. IKE, S. H. HYON, S. HTTOMI, H. WADA, Y. IKADA and Y. SHIMIZU
Cisplatin releasing bioresorbable micro spheres for the treatment of malignant ple
ural effusions 521
O. IKE, K. YANAGIHARA, T. HIRATA, T. FUKUSE, H. MIZUNO,
H. WADA and S. HITOMI
Low dose continuous administration of cisplatin for the postoperative chemother¬
apy of lung cancer 527
A. KOUDRINE
Zinc prevents apoptosis of adenocarcinoma cells in rate model 533
S. KOUKOURAKI, A. GIATROMANOLAKI, J. DAMELAKIS,
J. SKARLATOS, N. KARKAVITSAS, C. KOURAKOS,
V. GEORGOULIAS, H. KOUROUSIS and M. KOUKOURAKIS
99mTc sestamibi radionuclide excretion rate in lung cancer: possible implications
in predicting multi drug resistance 539
V. KOVCIN, S. JELIC, D. RADOSAVLJEVIC,
N. BABOVIC and S. RADULOVIC
Second line chemotherapy with high dose of Etoposide and Cisplatin for lung can¬
cer lack of activity 545
U. KUNZE, R SCHOBERBERGER, A. SCHMEISER RIEDER
and K.O. FAGERSTROM
Preventive oncology and nicotine addiction: first results of a field study 551
H. MULLER and I. CHATZISSAVVIDIS
Isolated thoracic perfusion (ITP) for the treatment of non small cell lung cancer
stage Illb/IV. A pilot study 555
Y. OTANI, I. YOSHIDA, S. SAKATA, S. ISHIKAWA, A. OHTAKI,
T. TAKAHASHI, S. OHKI, J. MURAKAMI and Y. MORISHITA
The effect of intraarterial neoadjuvant chemotherapy on thymus related malignant
mediastinal tumors 561
W.M. PADBERG, K. HENNEKING, J. BUHR and K. SCHWEMMLE
Long term survival, postoperative complications and hospital mortality after pul¬
monary resection in elderly patients with bronchogenic carcinoma over the age
of 70 567
Ch. COUROUSIS, N. ANDROULAKIS, P. HERAS, I. VAMVAKAS,
G. METAXARIS, J. SOUKLAKOS, F. VLASTOS, M. DMADI,
A.VOSSOS, P. ARAVOSUA, Th. GEORGOPOULOU, A. PAPANDREOU,
D. HATZIDAKI, Em. PAPADAKIS and V. GEORGOULIAS
Monotherapy with docetaxel in previously treated patients with advanced non
small cell lung carcinoma 571
F. FURMANIK, K. PAPROTA, M. DUDEK and S. JABLONKA
A non randomized study comparing preoperative chemotherapy plus surgery with
surgery alone in patients with locally advanced non small cell lung cancer . . . 575
A. POLYZOS, N. TSAVARIS, M. VESLEMES, T. DOSIOS,
C. KOSMAS and N. KATSILAMBROS
Cisplatin etoposide vs cisplatin + vinca + mitomycin for N.S.C.L.C. A phase III
study 579
T. SAWA, T. YOSHIDA, Y. OHNO, M. TOYOTA, N. YASUDA,
K. GOTO and H. FUJIWARA
Loperamide and Hange Shashinto combination treatment of diarrhea following
cisplatin and irinotecan combination chemotherapy for non small cell lung cancer. . 583
W. SCHUTTE, T. BLANKENBURG, I. BORK and ST. SCHADLICH
Paditaxel 3 hour iv administration therapy in advanced non small cell lung
CUT
cancer JO/
I. SPASOVA and L. HAVEL
The effects of neoadjuvant chemotherapy with cisplatin and vinorelbine on the
resectability of non small cell lung cancer stage IIIA/IIIB 591
G. ANTYPAS
The surgical treatment of lung cancer with chest wall invasion 595
P. TOMOS, N. TZATZADAKIS, A. MONIAKIS and N. BAILAS
Surgery for carina tumour ¦ V. BELTRAJVH, E SANTOBUONO and E. MASCITELLI
Centrally located N.S.C.L.C.: personal surgical experience through the years . . 607
T. DAHABREH, G. PAPAGIANAKIS, K. RAPTIS, D. GARBIS,
E. ZAHARIADIS, M. SALEH, C. ZISIS,
F. APOSTOLOPOULOU and H. KARAPISTOLIS
Surgery for bronchogenic carcinoma invading the chest wall. Operative risk and ^
postoperative complications T.I. DAHABREH . s
Quality of life in surgery of bronchogenic carcinoma 1 ¦
RJ. GINSBERG f,9 !
Treatment of multiple primary tumors of the lung 1 |
RJ. GINSBERG 6?3 |
Replase patterns after resection of non small cell lung cancer ;
P. GOLDSTRAW 6^5 I
Preoperative induction therapy in non small cell lung cancer JR IZBICKI WT KNOEFEL and S.B. HOSCH
The impact of radical systematic mediastinal lymphadenectomy on prognosis and ^
tumor staging in lung cancer j
^^fsurgery and post operative chemotherapy of Tl 3N2Mo stages of lung ^ j
cancer F. REA, M. LOY, M. MICHELON, F. CALABRO,
C. BREDA and F. SARTORI . , . • ,
Results of bronchial and tracheobronchial sleeve resection for lung cancc, *,th ^
N2 disease E. SEPSAS and O. MAIWAND 657
Cryotherapy N. ANDROULAKIS, C. KOUROUSIS, S. KAKOLYRISJP. HERAS,
G. MALTEZAKIS, L. VAMVAKAS, S. SCHLZA. G AGELAKI,
G. METAXARIS, J. VLACHONICOLIS, D. HATZIDAKI,
G. SAMONIS and V. GEORGOULIAS Horetaxel and
First line treatment of non small cell lung caranoma (NSCLC) with docetcael ^ ;
cis platin: preliminary results of a phase II study |
C. KOUROUSIS, N. ANDROULAKIS, S. KAKOLYRIS, L. VAMVAKAS,
P. HERAS, G. METAXARIS, G. MALTEZAKIS, G. CHALKIADAKIS,
J. VLACHONICOLIS, D. HATZIDAKI, G. SAMONIS and V. GEORGOULIAS
First line treatment of non small cell lung carcinoma (NSCLC) with docetaxel
and vinorelbine: a phase II study 673
Gy. OSTOROS and I. TALLOSY
The efficacy of follow up in totally resected NSCLC patients 681
I.C. PAPACHRISTOS, A.N.A. JILAIHAWI and D. PRAKASH
Results with radical resection in the management of malignant mesothelioma . . 685
G. PLAT, V. CANGEM, P. VOLPINO, N. D ANDREA and M.T. LONARDO
Surgical approach to Ilia NSC lung cancer: prognostic factors 689
D. ZIORA, J. KOZBELSKI and K. OKLEK
The protective role of cryoapplication against bleeding during flexible broncho
scopy. Preliminary report 693
M. VERCELLONI, S. FIESCHI, M. RAVINI, B. BARBDERI,
A. ANSELMI and PA. BELLONI
Completion pneumonectomy in malignancy 697
|
| any_adam_object | 1 |
| author_corporate | International Congress on Lung Cancer |
| author_corporate_role | aut |
| author_facet | International Congress on Lung Cancer |
| author_sort | International Congress on Lung Cancer |
| building | Verbundindex |
| bvnumber | BV011466683 |
| ctrlnum | (OCoLC)36598121 (DE-599)BVBBV011466683 |
| format | Conference Proceeding Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01427nam a2200349 c 4500</leader><controlfield tag="001">BV011466683</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">970801s1996 ad|| |||| 10||| engod</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)36598121</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV011466683</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield></datafield><datafield tag="111" ind1="2" ind2=" "><subfield code="a">International Congress on Lung Cancer</subfield><subfield code="n">2</subfield><subfield code="d">1996</subfield><subfield code="j">Verfasser</subfield><subfield code="0">(DE-588)1236686-9</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">2nd International Congress on Lung Cancer</subfield><subfield code="b">Crete, Greece, November 9 - 13, 1996</subfield><subfield code="c">ed. George Antypas</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">Second International Congress on Lung Cancer</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">Second International Congress on Lung Cancer</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Bologna</subfield><subfield code="b">Monduzzi</subfield><subfield code="c">1996</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">701 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Lung Neoplasms</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Lungenkrebs</subfield><subfield code="0">(DE-588)4036668-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1996</subfield><subfield code="z">Kreta</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Lungenkrebs</subfield><subfield code="0">(DE-588)4036668-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Antypas, George</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007714091&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-007714091</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 1996 Kreta gnd-content |
| genre_facet | Konferenzschrift 1996 Kreta |
| id | DE-604.BV011466683 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T18:10:16Z |
| institution | BVB |
| institution_GND | (DE-588)1236686-9 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-007714091 |
| oclc_num | 36598121 |
| open_access_boolean | |
| owner | DE-12 |
| owner_facet | DE-12 |
| physical | 701 S. Ill., graph. Darst. |
| publishDate | 1996 |
| publishDateSearch | 1996 |
| publishDateSort | 1996 |
| publisher | Monduzzi |
| record_format | marc |
| spelling | International Congress on Lung Cancer 2 1996 Verfasser (DE-588)1236686-9 aut 2nd International Congress on Lung Cancer Crete, Greece, November 9 - 13, 1996 ed. George Antypas Second International Congress on Lung Cancer Bologna Monduzzi 1996 701 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Lung Neoplasms Congresses Lungenkrebs (DE-588)4036668-6 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1996 Kreta gnd-content Lungenkrebs (DE-588)4036668-6 s DE-604 Antypas, George Sonstige oth HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007714091&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | 2nd International Congress on Lung Cancer Crete, Greece, November 9 - 13, 1996 Lung Neoplasms Congresses Lungenkrebs (DE-588)4036668-6 gnd |
| subject_GND | (DE-588)4036668-6 (DE-588)1071861417 |
| title | 2nd International Congress on Lung Cancer Crete, Greece, November 9 - 13, 1996 |
| title_alt | Second International Congress on Lung Cancer |
| title_auth | 2nd International Congress on Lung Cancer Crete, Greece, November 9 - 13, 1996 |
| title_exact_search | 2nd International Congress on Lung Cancer Crete, Greece, November 9 - 13, 1996 |
| title_full | 2nd International Congress on Lung Cancer Crete, Greece, November 9 - 13, 1996 ed. George Antypas |
| title_fullStr | 2nd International Congress on Lung Cancer Crete, Greece, November 9 - 13, 1996 ed. George Antypas |
| title_full_unstemmed | 2nd International Congress on Lung Cancer Crete, Greece, November 9 - 13, 1996 ed. George Antypas |
| title_short | 2nd International Congress on Lung Cancer |
| title_sort | 2nd international congress on lung cancer crete greece november 9 13 1996 |
| title_sub | Crete, Greece, November 9 - 13, 1996 |
| topic | Lung Neoplasms Congresses Lungenkrebs (DE-588)4036668-6 gnd |
| topic_facet | Lung Neoplasms Congresses Lungenkrebs Konferenzschrift 1996 Kreta |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007714091&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT internationalcongressonlungcancer 2ndinternationalcongressonlungcancercretegreecenovember9131996 AT antypasgeorge 2ndinternationalcongressonlungcancercretegreecenovember9131996 AT internationalcongressonlungcancer secondinternationalcongressonlungcancer AT antypasgeorge secondinternationalcongressonlungcancer |